Fewer Buprenorphine Initiation Episodes Seen During Pandemic

FRIDAY, Dec. 9, 2022 (HealthDay News) — The number of active prescriptions for buprenorphine remained stable during the COVID-19 pandemic, with fewer new treatment episodes and fewer episodes ending, according to a study published online Dec. 6 in the Journal of General Internal Medicine.

Bradley D. Stein, M.D., Ph.D., from the RAND Corporation in Pittsburgh, and colleagues examined the patterns of buprenorphine episodes during the pandemic using pharmacy claims representing approximately 92 percent of all prescriptions filled at retail pharmacies in the United States. The number of active, starting, and ending buprenorphine episodes was examined from March 13 to Dec. 1, 2020, and was compared with the expected number of such episodes based on growth from March 13 to Dec. 1, 2019.

The researchers found that in December 2020, the observed number of active buprenorphine episodes was comparable to the expected number, but between March 13 and Dec. 1, 2020, there were 17.2 percent fewer new treatment episodes than the expected number based on the 2019 experience. Similarly, between March 13 and Dec. 1, 2020, the number of episodes that ended was 16.0 percent fewer than expected. Decreases from expected episode starts and ends were seen throughout the study but were greatest in the two months following declaration of a public health emergency.

“While policy efforts may have been successful in maintaining existing patients in treatment, that success did not extend to individuals not yet in treatment,” Stein said in a statement. “We do not know why the number of patients starting treatment dropped so dramatically, although disruptions caused by the pandemic likely contributed to the trend.”

Abstract/Full Text (subscription or payment may be required)

io io io io io io io io io as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as io io io io io io io io io as as as as as as as as io io io io io io io io io io io io io io as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as as io io io io io io io io io as as as as as as as as io io io io io io io io io io io io io io io as as as as as as as as as as as as as as as as as as as as as as as lisa171 lisa172 lisa173 lisa174 lisa175 lisa176 lisa177 lisa178 lisa179 lisa180 lisa181 lisa182 lisa183 lisa184 lisa185 lisa186 lisa187 lisa188 lisa189 lisa190 lisa191 lisa192 lisa193 lisa194 lisa195 lisa196 lisa197 lisa198 lisa199 lisa200 lisa201 lisa202 lisa203 lisa204 lisa205 lisa206 lisa207 lisa208 lisa209 lisa210

NewToNews

Fewer Buprenorphine Initiation Episodes Seen During Pandemic

Byolaksjl

By olaksjl

Related Post

Study of Cannabidiol Oil for the Treatment of Advanced Cancer Symptoms

Comparing Extramural Lymphatic, Vascular, & Perineural Invasion with Intramural Invasion in Stage II Colon Cancer

Evaluation of a Self-Pay bpMRI Program’s Downstream Revenues

Leave a Reply Cancel reply

You missed

Can AI predict spatiotemporal distribution of dengue fever outbreaks with remote sensing data?

What emotions does the city awaken?

Novartis gets CDSCO panel nod for Phase III CT of anticancer drug Ianalumab

MDM2 inhibitor shows efficacy in patients with advanced cancers

NewToNews